Tech Company Financing Transactions
Eyenuk Funding Round
On 10/17/2022, Eyenuk secured $26 million in Series A funding from AXA Investment Managers, A&C Foelsgaard Alternativer and Eyenuk.
Transaction Overview
Company Name
Announced On
10/17/2022
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform's global commercialization and adoption.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
5850 Canoga Ave 250
Woodland Hills, CA 91367
USA
Woodland Hills, CA 91367
USA
Phone
Website
Email Address
Overview
Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening� for autonomous disease detection and AI Predictive Biomarkers� for risk assessment and disease surveillance. Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father's struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/17/2022: bolttech venture capital transaction
Next: 10/17/2022: Mobility Work venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs